Estrella Immunopharma Warrants ESLAW Hold Steady at 013 as Trading Range Tightens Biotech and Healthcare Lead US IPO Wave as Tech Companies Remain on Sidelines SKIL Q1 2026 Earnings EPS Misses Estimates Shares Dip 27 US Productivity Growth Eases in Q4 as Labor Costs Rise Raising Inflation Watch